CRISPR Therapeutics Delivery Strategies
- 1 Edición - 1 de marzo de 2027
- Última edición
- Editor: Prashant Kesharwani
- Idioma: Inglés
CRISPR Therapeutics Delivery Strategies is a structured and comprehensive resource in the rapidly evolving field of CRISPR technology. As CRISPR-Cas systems translate to therap… Leer más
Descripción
Descripción
CRISPR Therapeutics Delivery Strategies is a structured and comprehensive resource in the rapidly evolving field of CRISPR technology. As CRISPR-Cas systems translate to therapeutics, this reference provides critical insights into the challenges and advancements in effective delivery mechanisms. The book captures the essence of CRISPR's transformative potential in gene therapy, targeted cancer treatments, and personalized medicine, while also highlighting the importance of innovative delivery strategies to overcome existing barriers. The contents of the book offers a systematic exploration of CRISPR technology, beginning with foundational concepts and progressing to targeted drug delivery strategies. Each chapter explore specific applications, including CRISPR in cancer therapy, gene editing for rare diseases, and overcoming delivery barriers such as the blood-brain barrier. Additionally, ethical and regulatory considerations are addressed, providing a holistic view of the current landscape and future directions in CRISPR research. CRISPR Therapeutics Delivery Strategies serves as an essential resource for students, researchers, and professionals in the fields of pharmacology, biotechnology, and gene therapy. By compiling cutting-edge research and expert perspectives, this reference helps pharmaceutical scientists to navigate the complexities of CRISPR technology and its applications.
Puntos claves
Puntos claves
- Offers a comprehensive coverage of CRISPR-Cas technology from foundational concepts to advanced applications
- Covers in-depth exploration of innovative CRISPR-based drug delivery approaches
- Presents insights into ethical, regulatory, and safety considerations surrounding CRISPR technology
De interès para
De interès para
Pharmaceutica scientists in academia, advanced students at PhD level
Índice
Índice
SECTION 1: FUNDAMENTALS OF CRISPR TECHNOLOGY: BREAKTHROUGH IN GENETIC ENGINEERING
1.Introduction to CRISPR: Overview and historical milestones in gene editing
2. Basics of drug delivery and gene editing
3. Understanding the science behind CRISPR mechanism
4. Potential of CRISPR technology in drug delivery
5. Role of CRISPR in targeted delivery: Synergy of nanoparticles and CRISPR
SECTION 2: CRISPR BASED TARGETED DRUG DELIVERY STRATEGIES
6. Viral Vectors and CRISPR: A Common Approach to Drug Delivery
7. Non-Viral Delivery Systems: CRISPR and Alternative Carriers
8. CRISPR in RNA Drug Delivery: mRNA and Beyond
SECTION 3: APPLICATIONS OF CRISPR BASED TARGETED THERAPEUTICS
9. CRISPR in Cancer Drug Delivery: Precision Medicine at Work
10. CRISPR-Based Gene Editing for Rare Diseases
11. Delivering CRISPR to the Brain: Overcoming the Blood-Brain Barrier
12. Immunomodulation and CRISPR in Drug Delivery
13. CRISPR in Vaccine Development and Delivery
14. Overcoming Delivery Barriers: Stability, Bioavailability, and Half-Life
SECTION 4: CHALLENGES, ETHICAL AND REGULATORY ASPECTS
15. CRISPR for Chronic Diseases: Challenges in Long-Term Therapeutic Approaches
16. Safety and Ethical Concerns in CRISPR Drug Delivery
17. Legal, and Social Implications of CRISPR in Drug Delivery
18. Regulatory Frameworks and Oversight in CRISPR-Based Therapies
SECTION 5: FUTURE DIRECTIONS, CLINICAL TRIALS, AND CONCLUSION
19. CRISPR in Stem Cell Therapy: A Path to Regenerative Medicine
20. Clinical Trials: The Reality of CRISPR Drug Delivery
21. Innovative CRISPR Delivery Strategies: Future Directions
22. Conclusion: The Transformative Potential and Impact of CRISPR Drug Delivery Systems in Healthcare and Pharmaceutical Industries
1.Introduction to CRISPR: Overview and historical milestones in gene editing
2. Basics of drug delivery and gene editing
3. Understanding the science behind CRISPR mechanism
4. Potential of CRISPR technology in drug delivery
5. Role of CRISPR in targeted delivery: Synergy of nanoparticles and CRISPR
SECTION 2: CRISPR BASED TARGETED DRUG DELIVERY STRATEGIES
6. Viral Vectors and CRISPR: A Common Approach to Drug Delivery
7. Non-Viral Delivery Systems: CRISPR and Alternative Carriers
8. CRISPR in RNA Drug Delivery: mRNA and Beyond
SECTION 3: APPLICATIONS OF CRISPR BASED TARGETED THERAPEUTICS
9. CRISPR in Cancer Drug Delivery: Precision Medicine at Work
10. CRISPR-Based Gene Editing for Rare Diseases
11. Delivering CRISPR to the Brain: Overcoming the Blood-Brain Barrier
12. Immunomodulation and CRISPR in Drug Delivery
13. CRISPR in Vaccine Development and Delivery
14. Overcoming Delivery Barriers: Stability, Bioavailability, and Half-Life
SECTION 4: CHALLENGES, ETHICAL AND REGULATORY ASPECTS
15. CRISPR for Chronic Diseases: Challenges in Long-Term Therapeutic Approaches
16. Safety and Ethical Concerns in CRISPR Drug Delivery
17. Legal, and Social Implications of CRISPR in Drug Delivery
18. Regulatory Frameworks and Oversight in CRISPR-Based Therapies
SECTION 5: FUTURE DIRECTIONS, CLINICAL TRIALS, AND CONCLUSION
19. CRISPR in Stem Cell Therapy: A Path to Regenerative Medicine
20. Clinical Trials: The Reality of CRISPR Drug Delivery
21. Innovative CRISPR Delivery Strategies: Future Directions
22. Conclusion: The Transformative Potential and Impact of CRISPR Drug Delivery Systems in Healthcare and Pharmaceutical Industries
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Publicado: 1 de marzo de 2027
- Idioma: Inglés
Sobre el editor
Sobre el editor
PK
Prashant Kesharwani
Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.
Afiliaciones y experiencia
Dr. Harisingh Gour Vishwavidyalaya University, India